AirSculpt Technologies Inc. (AIRS)
NASDAQ: AIRSHealth CareMedical/Nursing ServicesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
AIRS stock chart
Technical analysisKey statistics
All statistics- Market cap
- $43.67M
- EPS (TTM)
- -$0.12
- Dividend yield
- None
- Ex-dividend date
- Aug 25, 2022
- 52-week range
- 0.516 – 5.79
- Day range
- 0.5229 – 0.6453
- Volume / Avg
- 2.03M / 1.27M
- Beta
- —
- Shares outstanding
- 73.93M
52-week range
AIRS stock today
On Nov 20, AIRS ended the session at $0.5907, shedding $0.0636 (9.72%), versus the S&P 500's 3.70% decline. Shares are 89.8% below their 52-week high of $5.79, set on Jun 4, 2026 and 14.5% above the 52-week low of $0.516, near the bottom of the past year's range. AIRS is down 70.2% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 83.9%.
AirSculpt Technologies has posted a net loss over the last twelve months (EPS of -$0.12), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About AirSculpt Technologies
Company profileAirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States and Canada. The company offers AirSculpt, a body contouring treatment that removes fat and tightens skin while sculpting targeted areas of the body in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool.
- Sector
- Health Care
- Industry
- Medical/Nursing Services
- CEO
- Mr. Yogesh Jashnani
- Headquarters
- Tampa, FL
- Employees
- 330
- IPO year
- 2021
- Website
- airsculpt.com
Financial highlights
Full financialsIn fiscal 2025, AirSculpt Technologies generated $151.8 million in revenue, down 15.8% from fiscal 2024, its first annual decline since 2024. AirSculpt Technologies reported a net loss of $11.7 million, compared with a loss of $8.0 million a year earlier. Gross margin was 59.4% (down from 60.5%) and operating margin -7.6%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $151.82M | $180.35M | $195.92M | $168.79M | $133.31M |
| Growth | -15.82% | -7.95% | +16.07% | +26.61% | +112.40% |
| Net income | $-11.67M | $-8.02M | $-4.24M | $-14.68M | $10.55M |
| EPS (diluted) | $-0.19 | $-0.14 | $-0.08 | $-0.26 | $-0.01 |
Analyst forecast
ForecastConsensus (3 analysts)
none
Avg. price target
$4.50+661.81%
- Strong buy 1
- Buy 0
- Hold 2
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 6, 2026
- EPS actual vs est.
- $-0.10 vs —
Dividends
Dividend history- Annual dividend
- $0.00
- Last payment
- $0.41
- Ex-dividend date
- Aug 25, 2022
AIRS news
All AIRS news- AirSculpt Technologies Announces First-Ever Nationwide Open House Event, "The Gift of Body Confidence"GlobeNewswire
- Friday's ETF Movers: PSI, RSSLNasdaqSITM, WOLF, AIRS, CVRX
- AirSculpt (AIRS) Q3 2026 Earnings Call TranscriptNasdaq
- Friday Sector Laggards: Hospital & Medical Practitioners, Packaging & ContainersNasdaqAIRS, STLN, KRT, OI
- AirSculpt Technologies, Inc. Enters into $39.0 million Financing Agreement and Reduces 2026 GuidanceNasdaq
- AirSculpt Technologies, Inc. Reports Third Quarter Fiscal 2026 ResultsNasdaq
- AirSculpt Technologies Reports Third Quarter Fiscal 2026 ResultsGlobeNewswire
- AirSculpt Technologies Announces Earnings Release Date, Conference Call, and Webcast for Third Quarter Fiscal 2026 ResultsGlobeNewswire
AirSculpt Technologies peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| EUDAEUDA Health Holdings Limited Class A | 15.96 | -7.69% | $47.79M | vs AIRS |
| ALPSALPS Group Inc | 1.15 | -3.36% | $36.43M | vs AIRS |
| NAKANakamoto Inc. | 3.44 | -15.89% | $63.11M | vs AIRS |
| LFMDLifeMD Inc. | 1.45 | -9.40% | $69.84M | vs AIRS |
| DCGODocGo Inc. | 0.175 | +1.98% | $17.32M | vs AIRS |
| CCMConcord Medical Services Holdings Limited ADR | 3.55 | -1.11% | $15.41M | vs AIRS |
| BMGLBasel Medical Group Ltd | 0.3832 | +20.01% | $5.20M | vs AIRS |
| ATPCAgape ATP Corporation | 1.16 | -15.94% | $1.16M | vs AIRS |
Indexes, lists and sector
AirSculpt Technologies stock FAQ
What is AirSculpt Technologies's stock price today?
AIRS last traded at $0.5907 as of Nov 20, 4:00 PM EST, down 9.72% on the day. Prices are delayed at least 15 minutes.
Does AirSculpt Technologies pay a dividend?
Yes. AirSculpt Technologies pays $0.00 per share annually. The most recent dividend of $0.41 had an ex-dividend date of Aug 25, 2022.
Who is AirSculpt Technologies's CEO?
Mr. Yogesh Jashnani is the chief executive officer of AirSculpt Technologies Inc., which has about 330 employees.
What is the AIRS 52-week high?
The 52-week high for AIRS is $5.79 and the 52-week low is $0.516. The stock is currently 89.8% below its high.